# Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination

> **NCT01357720** · PHASE4 · COMPLETED · sponsor: **Crucell Holland BV** · enrollment: 400 (actual)

## Conditions studied

- Diphtheria
- Pertussis
- Tetanus
- Hepatitis B
- Haemophilus Infections

## Interventions

- **BIOLOGICAL:** Quinvaxem
- **BIOLOGICAL:** Quinvaxem/Tritanrix

## Key facts

- **NCT ID:** NCT01357720
- **Lead sponsor:** Crucell Holland BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2013-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357720, "Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01357720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*